Evidence map›Paper›PMID 28765224›Full record

ArticlemBio2017

Genome-Wide Sensitivity Analysis of the Microsymbiont

Markus F F Arnold, Mohammed Shabab, Jon Penterman, Kevin L Boehme, Joel S Griffitts, Graham C Walker

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
12.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 60 citations in OpenAlex.

  1. Artificial intelligence catalyzes antimicrobial peptide design.Synthetic and systems biotechnology · 2027
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Transcriptomic response ofFrontiers in microbiology · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Uncovering the Hidden Credentials ofMicrobiology and molecular biology reviews : MMBR · 2021
    Review
  19. Highly Efficient CRISPR-Mediated Base Editing inFrontiers in microbiology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Markus F F ArnoldDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Mohammed ShababDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jon PentermanDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Kevin L BoehmeDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA.
Joel S GriffittsDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA.
Graham C WalkerDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA gwalker@mit.edu.
Massachusetts Institute of Technology · USBrigham Young University · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Paula T Hammond · 1985 to 2026
$93.9M
MOLEULAR GENETICS OF RHIZOBIUM PLASMIDSR01GM031030 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WALKER, GRAHAM C · 1985 to 2020
$8.6M
NCI NIH HHS P30 CA014051NIGMS NIH HHS R01 GM031030
6 · The paper itself

Abstract

The model legume species

Indexed as

SymbiosisBacterial ProteinsCysteineDefensinsHigh-Throughput Nucleotide SequencingMedicago truncatulaMembrane Transport ProteinsMutagenesisNitrogen FixationSinorhizobium melilotiBacterial ProteinsCysteineDefensinsMembrane Transport Proteinsantimicrobial peptideshost-microbe interactionssymbiosis

Identifiers

PMID28765224
PMCPMC5539429
OpenAlexW2741747812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.